ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Short-term Pre-OPerative Durvalumab (MEDI 4736) in Early Small Triple Negative Breast Cancer Patients (POP-Durva)

Gustave Roussy, Cancer Campus, Grand Paris · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
early small (ct1n0) triple negative breast cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 914899
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.